Net Loss per Share (Tables)

9 Months Ended

12 Months Ended

Sep. 30, 2015

Dec. 31, 2014

Net Loss Per Share Tables

Potentially dilutive securities

	As of September 30,
	2015		2014
Stock options		3,243,041		242,893
Restricted stock awards		2,300,850		—
Redeemable convertible preferred stock		—		1,250,000
Preferred stock		22,482,400		2,881,811
Common stock warrants		5,959,668		2,133,386
Total		33,985,959		6,508,090

The table below presents the potentially dilutive securities that would have been included in the calculation of diluted net loss per share if they were not antidilutive for the periods presented.

	Years Ended December 31,
	2014		2013
Stock options		44,615		103,417
MabVax Series A redeemable convertible preferred stock		137,607		265,749
MabVax Series B redeemable convertible preferred stock		156,247		189,020
MabVax Series C-1 redeemable convertible preferred stock		412,444		—
Series B redeemable convertible preferred stock		102,895		—
Series A-1 preferred stock		742,658		—
Series C preferred stock		47,023		—
Total		1,643,489		558,186